Fundamental Analysis of Shockwave Medical Inc - Growth / Value Index


SWAV - Valuation Highlights

Valuation Analysis

   Tremendous increasing in Book Value last 3 year
   Tsr Value Index - Poor Score of 26.56
   Price to Earning Ratio is 77.26 and EV to EBITDA is 76.43 suggesting that it is very expensive
   Price to Book Ratio of 19.68 suggesting that it is very expensive
Valuation Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Price to Earning 78.34 86.84 69.34 %
Price to Book 19.96 19.13 -11.71 % 17.13
Price to Sales 16.26 17.51 -22.56 %
Enterprise Value to EBITDA Multiple 77.46 74.83 -16.10 %


SWAV - Profitability Highlights

Profitability Analysis

   Excellent QoQ /QoQ FY EPS growth
   Company Earning excess return
   During the past twelve months, the company has given a strong Return On Equity of 25.47%
   All key Trailing Twelve Months Margin growing by 15 %
   Company's Net Profit is increasing for last 5 Quarters
   EBITDA is continuously increasing for last 3 Years
   Steady Growth in EPS for last four quarters
   Good Return On Capital Employed of 10.52
   Good Net Margin of 20.75% is achieved by the company
   Very Low Dividend Yield of 0 %
Profitability Key Ratios
Ratio TTM Latest FY Yoy Change MRQ
Return On Equity 25.47 22.03 -47.86 % 7.36
Return On Asset 13.07 9.40 -71.88 % 3.37
Net Profit Margin 20.75 20.17 -54.27 % 25.29
Operating Profit Margin 20.68 22.73 -10.32 % 19.38
EBITDA Margin 21.26 24.15 -3.62 % 19.38


Highlights
Market Cap12567.69 M
Enterprise Value12974.77 M
Price/Book TTM19.96
Outstanding Share37543.50 K
Float/ Outstanding Share98.38%
Dividend Yield0 %
Share Holding
Guru Numbers
Price/Graham No8.16
Peter Lynch Ratio-0.523
Piotroski F Score6.00
Altman Z Score10.17
Sloan Ratio-0.0311
Peter Lynch Fair Value106.82


SWAV - Growth Highlights

Growth Analysis

   Short term positive trend in total sale and net profit
   STRONG JUMP IN NET SALE : YoY growth
   Tremendous increasing trend in total sale last 3 year
   Quarterly sales in last 5 years is trending up
   Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field TTM YoY Growth QoQ Growth
Revenue 787969 K 49.11 % 7.80 %
Gross Profit 685440 K 49.47 % 7.28 %
EBITDA 167501 K 43.70 % 11.02 %
Net Profit 163499 K 31.81 % 24.92 %
EPS 4.27 40.95 % NA


SWAV - Stability Highlights

Stability Analysis

   Altman Z Score of 10.06 suggests good Stability
   Cash ratio of 9.51
   Company financial liquidity has improved
Stability Key Ratios
Ratio Latest FY Yoy Change MRQ
Debt to Equity Ratio 1.10 2107.63 % 0.980
Cash Ratio 9.51 97.84 %
Quick Ratio 10.73 76.94 % 12.61
Shareholders Equity 42.68 -46.06 %
Debt to EBITDA 4.17 1909.03 %


Historical Valuation Ratios of Shockwave Medical Inc

Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Shockwave Medical Inc

Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Shockwave Medical Inc

Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Shockwave Medical Inc

Historical Solvency Ratios
Loading ...


Note : All Data Generated at the End of Trading Hours (EOD Data)